Welcome to our dedicated page for Steakholder Foods Ltd. SEC filings (Ticker: MTTCF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Steakholder Foods Ltd. filings document foreign private issuer reporting on Form 6-K, including material agreements, ADS-related capital actions, registration-statement incorporation, and governance changes. Recent reports describe amendments to an equity-line purchase agreement, resale-registration context, and capital-structure disclosures tied to the company’s American depositary share program.
The filings also cover corporate events involving Twine Solutions Ltd., including acquisition-related financial statements, pro forma combined financial information, subsidiary funding decisions, insolvency-related disclosures and board resignations connected to subsidiary administration. These records frame the company’s formal disclosures around operations, financing, governance and foreign-issuer reporting status.
Steakholder Foods Ltd. (STKH) announced the commercial launch of its Perfecta™ Premium Plant-Based Meat line at retail locations across the Northeastern United States, its first placement on U.S. store shelves. Distribution is being handled through KeHE Distributors, a major U.S. natural and specialty food distributor.
The launch is part of a phased strategy focused on building brand awareness and consumer trial in the Northeast while laying groundwork for broader U.S. expansion and additional distribution partnerships. Perfecta is positioned as a next-generation plant-based protein platform offering both whole-cut and traditional formats designed to closely replicate meat and seafood taste, texture, and appearance, supported by Steakholder Foods’ 3D-printing technology and proprietary premix blends.
Steakholder Foods Ltd. (STKH) reported unaudited results for the six months ended June 30, 2026, showing an early‑stage business still pre‑revenue but expanding commercialization efforts. Revenue remained $0, while a first‑time inventory write‑off drove cost of goods sold of $0.3 million and a total comprehensive loss of $3.3 million, down 15% from $3.8 million a year earlier.
Operating expenses shifted: research and development fell 33% to $0.8 million and general and administrative declined 19% to $1.6 million, while marketing rose to $0.6 million as the company prepared its U.S. launch of the Perfecta plant‑based meat platform and continued development and sales of 3D‑printing production machines. Cash and cash equivalents were $1.1 million at June 30, 2026 versus $3.1 million at year‑end 2025, with an accumulated deficit of $93.2 million and shareholders’ equity of $2.27 million.
Management states there is substantial doubt about the company’s ability to continue as a going concern because existing cash is not sufficient for at least 12 months. Subsequent to June 30, 2026, Steakholder Foods raised about $4.3–4.7 million net through a July 2026 private placement, warrant exercises and use of an $8.0 million equity line, and estimates pro forma shareholders’ equity of ~$6.57 million, above Nasdaq’s $2.5 million equity requirement. The company also discloses risk that its Market Value of Listed Securities, approximately $4.8 million on August 20, 2026, could trigger future Nasdaq delisting under a proposed new rule if implemented.
Steakholder Foods Ltd. is calling a Special General Meeting on September 15, 2026 in Ness Ziona, Israel. Shareholders will vote on two key items: (1) an increase in authorized share capital and (2) approval to issue American Depositary Shares (ADSs) underlying pre-funded warrants from a July 2026 private placement.
In that financing, the company issued Pre-Funded Warrants and Series E and F Warrants to purchase up to 1,750,000 ADSs each, at a combined purchase price of $1.99 per pre-funded unit, generating approximately $3.5 million in gross proceeds. Each ADS represents 12,000 ordinary shares. Current authorized share capital is 50,000,000,000 ordinary shares, with 12,173,080,659 ordinary shares outstanding as of August 5, 2026.
The board proposes increasing authorized capital by 999,950,000,000,000 to a total of 1,000,000,000,000,000 ordinary shares to enable full exercise of the new and existing warrants and provide additional capacity for future needs. Shareholders are also asked to approve issuance of all ordinary shares underlying the pre-funded warrants, which, if fully exercised, would result in 1,750,000 ADSs (21,000,000,000 ordinary shares) for the investor, potentially making it a controlling shareholder under Israeli law.
Steakholder Foods Ltd. entered into a definitive securities purchase agreement for a private placement of pre-funded warrants and unregistered Series E and Series F warrants, each series covering up to 1,750,000 ADSs, with each ADS representing 12,000 ordinary shares. The transaction closed on August 3, 2026, generating approximately $3.5 million in gross proceeds, assuming full exercise of the pre-funded warrants.
The Series E and F warrants have an exercise price of $2.00 per ADS, become exercisable after shareholder approval of an authorized share increase, and expire 18 months and five years, respectively, after the later of the resale registration effectiveness and that approval. If fully exercised in cash, the warrants could provide approximately $7 million in additional gross proceeds. Use of proceeds is for research and development, business growth, working capital and general corporate purposes.
Warrants include a 4.99% beneficial ownership cap and allow cashless exercise for Ordinary Warrant ADSs if no effective resale registration exists. H.C. Wainwright & Co. acted as exclusive placement agent, earning a 7.5% cash fee, expense reimbursements and 122,500 placement agent warrants at $2.50 per ADS. The company agreed to near-term restrictions on additional issuances and to avoid “variable rate transactions” for one year, and entered into a Registration Rights Agreement to register the warrant ADSs for resale.
Steakholder Foods Ltd. plans to adjust the ratio of its American Depositary Shares so that one ADS will represent 12,000 ordinary shares, replacing the prior ratio of one ADS representing 4,000 ordinary shares. The new ratio is effective on July 27, 2026.
This change will function as a one-for-three reverse ADS split, with every three existing ADSs exchanged for one new ADS, requiring no action from holders. No additional ADSs will be issued, and fractional ADSs will be aggregated, sold, and the net proceeds distributed to affected ADS holders.
Steakholder Foods Ltd. filed a Form 6-K to share a press release about expanding U.S. access to its Perfecta™ Premium Plant-Based Meat line. The company has secured expanded retail distribution through KeHE Distributors, one of the largest natural and specialty food distributors in the United States.
The initial rollout of Perfecta products, including plant-based marbled steak, filet mignon, chicken breast, burgers, and fish patties, is expected to begin in the Northeastern United States, with a structured roadmap for broader U.S. expansion through Q3 and Q4 2026.
Steakholder Foods Ltd. entered into inducement agreements with certain warrant holders for the immediate cash exercise of existing warrants to buy 892,854 ADSs at a reduced exercise price of $1.25 per ADS, down from $5.00 per ADS. The company expects gross proceeds of about $1.1 million before fees and expenses and plans to use the net proceeds for working capital, business growth, potential repurchases of its securities, and general corporate purposes.
In return, Steakholder Foods will issue new Series C and Series D warrants to purchase up to a combined 1,785,708 ADSs at $1.25 per ADS, plus placement agent warrants to buy 62,500 ADSs at $1.5625 per ADS. H.C. Wainwright & Co. will receive a 7.5% cash fee on gross proceeds and additional expense reimbursements. The new securities are being offered in a private placement under Section 4(a)(2), with a commitment to file a resale registration statement and certain limitations on new issuances and variable rate transactions after closing.
Steakholder Foods Ltd. plans to launch its new Perfecta premium plant-based meat line in the U.S. in the second half of 2026 under the slogan “Plant-Based Meat, Perfected!”. The product is positioned as a next-generation plant-based protein platform aimed at delivering the taste, texture, and whole-cut eating experience of conventional meat.
The rollout is expected to start in the Northeastern United States and then expand to wider retail distribution as supply chain and marketing efforts scale. Management describes this U.S. entry as an important step toward commercialization of its 3D-printing technology and proprietary premix blends for alternative proteins.
Steakholder Foods Ltd. reports amendments to its Any Market Purchase Agreement with Alumni Capital, which provides an $8 million equity line of credit allowing sales of the company’s ADSs from time to time. A March 25, 2026 amendment shortens settlement to within two business days after a purchase notice, with pricing set no later than the following business day. A May 5, 2026 amendment extends the agreement’s effective period by one year to June 30, 2027. The amendments are expected to take effect upon effectiveness of a registration statement covering the resale of shares issued under the agreement.
Steakholder Foods Ltd. files its annual Form 20-F outlining an early-stage alternative protein business focused on three-dimensional printing of meat-like products and branded end products via distributors. The company reports cumulative net losses of about USD 89.9 million since inception and its auditors raise substantial doubt about its ability to continue as a going concern.
The report stresses that initial revenues only began in late 2024, with no assurance of achieving profitable commercialization or sufficient demand for its food production machines and products. Steakholder highlights heavy future funding needs, potential dilution from additional capital raises, intense competition in alternative proteins, regulatory and food-safety exposure, and operational risks tied to limited manufacturing experience, key suppliers, key personnel and concentration of customers, as well as geopolitical and trade risks linked to its operations in Israel.